An at-home nasal spray treatment for COVID-19 will be put to the test by Melbourne biomedical researchers, as the University of Melbourne and Monash University receive $4.2 million to establish a six-month clinical trial lead by Northern Hospital in collaboration with Oxford University. Heparin, a widely used blood-thinning drug to treat or prevent blood clots […]
Read More… from COVID-19 nasal spray heads to clinical trial